Scaffold-based 3D cell culture models in cancer research

Abstract

Three-dimensional (3D) cell cultures have emerged as valuable tools in cancer research, offering significant advantages over traditional two-dimensional (2D) cell culture systems. In 3D cell cultures, cancer cells are grown in an environment that more closely mimics the 3D architecture and complexity of in vivo tumors. This approach has revolutionized cancer research by providing a more accurate representation of the tumor microenvironment (TME) and enabling the study of tumor behavior and response to therapies in a more physiologically relevant context. One of the key benefits of 3D cell culture in cancer research is the ability to recapitulate the complex interactions between cancer cells and their surrounding stroma. Tumors consist not only of cancer cells but also various other cell types, including stromal cells, immune cells, and blood vessels. These models bridge traditional 2D cell cultures and animal models, offering a cost-effective, scalable, and ethical alternative for preclinical research. As the field advances, 3D cell cultures are poised to play a pivotal role in understanding cancer biology and accelerating the development of effective anticancer therapies. This review article highlights the key advantages of 3D cell cultures, progress in the most common scaffold-based culturing techniques, pertinent literature on their applications in cancer research, and the ongoing challenges. Graphical Abstract

Titania–Graphene Oxide Nanocomposite-Based Philadelphia-Positive Leukemia Therapy

“…The Rat-1 cells are fibroblasts with no stacking behavior; however, after oncogene insertion, they started to stack over adjacent cells, forming multiple layers. This is a characteristic behavior of oncogenic cells, which is absent in healthy fibroblasts …”

Application of 3D, 4D, 5D, and 6D bioprinting in cancer research: what does the future look like?

“…These cells are then integrated into a suitable biomaterial, chosen based on the specific bioprinting method employed. 115–117 This development of in vitro cancer models capable of emulating drug responses unique to each patient is a major focus in personalized medicine. 118 Despite this, the current technologies used in crafting such models primarily reproduce only the morphological diversity found in human cancer tissues.…”

Recent Advancements in Bone Tissue Engineering: Integrating Smart Scaffold Technologies and Bio-Responsive Systems for Enhanced Regeneration

“…When embedded within scaffolds, ESCs can be directed to form not only bone but also supportive vascular and connective tissues in the development of complex, integrated tissue structures. Their pluripotency, combined with their high proliferative ability, makes ESCs a powerful but ethically sensitive option in scaffold fabrication due to their acquisition from embryos [ 68 ].…”